{"transactions":[{"id":778910,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":47318,"kind":"person","name":"Galli Stephen J","position":1,"cik":"0001551951","reported_name":"Galli Stephen J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-14T20:25:23.000Z","date":"2026-05-12","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs shall vest on the first anniversary of May 12, 2026."}],"balance_after":10006,"source":{"system":"sec-edgar","filing":"0001193125-26-224133","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000119312526224133/ownership.xml","form_type":"4"}},{"id":1145298,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":47318,"kind":"person","name":"Galli Stephen J","position":1,"cik":"0001551951","reported_name":"Galli Stephen J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-05-16T20:05:12.000Z","date":"2025-05-15","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options shall vest on a quarterly basis over 12 months following May 15, 2025, subject to the Reporting Person's continued service through each applicable vesting date. The options were issued on May 15, 2025 with an exercise price of $0.99, representing the closing stock price on May 15, 2025."}],"balance_after":125000,"derivative":{"exercise_price":0.99,"expiration_date":"2035-05-15","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0000950170-25-073517","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000095017025073517/ownership.xml","form_type":"4"}},{"id":1465739,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":47318,"kind":"person","name":"Galli Stephen J","position":1,"cik":"0001551951","reported_name":"Galli Stephen J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-07-01T20:00:06.000Z","date":"2024-06-27","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options shall vest on a quarterly basis over 12 months following June 27, 2024, subject to the Reporting Person's continued service through each applicable vesting date. The options were issued at approximately 9:30 a.m. (ET) on June 27, 2024 with an exercise price of $1.05, representing the most recently reported closing stock price on June 26, 2024."}],"balance_after":125000,"derivative":{"exercise_price":1.05,"expiration_date":"2034-06-27","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0000950170-24-079558","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000095017024079558/ownership.xml","form_type":"4"}},{"id":1902689,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":47318,"kind":"person","name":"Galli Stephen J","position":1,"cik":"0001551951","reported_name":"Galli Stephen J","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2023-05-05T23:35:00.000Z","date":"2023-05-04","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options shall vest on a quarterly basis over the next 12 months.  The options were issued at approximately 9:50 a.m. (ET) on May 4, 2023, with an exercise price of $0.662, representing the most recently reported closing stock price on May 3, 2023."}],"balance_after":125000,"derivative":{"exercise_price":0.662,"expiration_date":"2033-05-04","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001437749-23-012868","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000143774923012868/rdgdoc.xml","form_type":"4"}},{"id":2270261,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":47318,"kind":"person","name":"Galli Stephen J","position":1,"cik":"0001551951","reported_name":"Galli Stephen J","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2022-05-16T22:23:21.000Z","date":"2022-05-13","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options shall vest on a quarterly basis over the next 12 months. Option grant was issued at 9:30 a.m. (ET) on May 13, 2022, with an exercise price of $0.93, representing the most recently reported closing stock price on May 12, 2022."}],"balance_after":50000,"derivative":{"exercise_price":0.93,"expiration_date":"2032-05-13","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001437749-22-012712","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000143774922012712/rdgdoc.xml","form_type":"4"}},{"id":2708037,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":47318,"kind":"person","name":"Galli Stephen J","position":1,"cik":"0001551951","reported_name":"Galli Stephen J","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2021-05-18T20:18:54.000Z","date":"2021-05-14","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options shall vest on a quarterly basis over the next 12 months. Option grant was issued at 4:30 p.m. (ET) on May 14, 2021 with an exercise price of $2.90, representing the most recently reported closing stock price at the time of grant."}],"balance_after":50000,"derivative":{"exercise_price":2.9,"expiration_date":"2031-05-14","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001437749-21-012678","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000143774921012678/rdgdoc.xml","form_type":"4"}},{"id":3142658,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":47318,"kind":"person","name":"Galli Stephen J","position":1,"cik":"0001551951","reported_name":"Galli Stephen J","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2020-05-19T18:05:31.000Z","date":"2020-05-15","kind":"grant","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options shall vest on a quarterly basis over the next 12 months. Option grant was issued at 4:30 p.m. (ET) on May 15, 2020 with an exercise price of $1.70, representing the most recently reported closing stock price at the time of grant."}],"balance_after":45000,"derivative":{"exercise_price":1.7,"expiration_date":"2030-05-15","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001437749-20-011261","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000143774920011261/rdgdoc.xml","form_type":"4"}},{"id":3516847,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":47318,"kind":"person","name":"Galli Stephen J","position":1,"cik":"0001551951","reported_name":"Galli Stephen J","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2019-05-22T00:07:13.000Z","date":"2019-05-17","kind":"grant","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options shall vest on a quarterly basis over the next 12 months. Option grant was issued at 9:00 a.m. (ET) on May 17, 2019 with an exercise price of $2.52, representing the most recently reported closing stock price at the time of grant."}],"balance_after":45000,"derivative":{"exercise_price":2.52,"expiration_date":"2019-05-17","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001437749-19-010646","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000143774919010646/rdgdoc.xml","form_type":"4"}},{"id":3880461,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":47318,"kind":"person","name":"Galli Stephen J","position":1,"cik":"0001551951","reported_name":"Galli Stephen J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-06-29T20:02:31.000Z","date":"2018-06-27","kind":"grant","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options shall vest on a quarterly basis over the next 12 months."}],"balance_after":45000,"derivative":{"exercise_price":2.38,"expiration_date":"2028-06-27","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001615774-18-005995","document":"s111129_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000161577418005995/s111129_form4.xml","form_type":"4"}},{"id":4302947,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":47318,"kind":"person","name":"Galli Stephen J","position":1,"cik":"0001551951","reported_name":"Galli Stephen J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-05-26T17:44:07.000Z","date":"2017-05-24","kind":"grant","acquired":true,"shares":64132,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options shall vest on a quarterly basis over the next 12 months."}],"balance_after":88263,"derivative":{"exercise_price":0.47,"expiration_date":"2027-05-24","underlying":"Common Stock","underlying_shares":64132},"source":{"system":"sec-edgar","filing":"0001615774-17-002739","document":"s106361_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000161577417002739/s106361_form4.xml","form_type":"4"}}]}